Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease - a podcast by ReachMD

CME credits: 0.25

Valid until: 30-12-2022

Claim your CME credit at https://reachmd.com/programs/cme/keeping-pace-in-lung-cancer-integration-of-immune-checkpoint-inhibitors-as-initial-therapy-for-advanced-disease/13147/

Medical innovation in the treatment of lung cancer is at an all-time high. However, the gap between recent developments and their adoption into clinical practice continues to expand for community oncologists as the plethora of scientific and clinical data for the treatment of NSCLC rapidly emerges. Dr. Mark Socinski and Dr. Sandip Patel go through the selection and management of immune checkpoint inhibitors for patients with advanced NSCLC who do not have an actionable mutation.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD